奧卡西平致Stevens-Johnson綜合征和中毒性表皮壞死松解癥的特點(diǎn)及基因相關(guān)性分析
本文選題:奧卡西平 切入點(diǎn):Stevens-Johnson綜合征 出處:《中國(guó)藥房》2017年05期 論文類型:期刊論文
【摘要】:目的:探討奧卡西平致Stevens-Johnson綜合征(SJS)和中毒性表皮壞死松解癥(TEN)的臨床特點(diǎn)及其基因多態(tài)性。方法:計(jì)算機(jī)檢索中國(guó)知網(wǎng)(CNKI)、萬(wàn)方、維普、PubMed、EMBase、SpringerLink等數(shù)據(jù)庫(kù),對(duì)有關(guān)奧卡西平引起嚴(yán)重皮膚不良反應(yīng)的個(gè)案報(bào)道文獻(xiàn)進(jìn)行整理和分析。結(jié)果:收集文獻(xiàn)12篇,獲取奧卡西平引發(fā)SJS/TEN的病例報(bào)道13例。奧卡西平的嚴(yán)重皮膚不良反應(yīng)發(fā)生于男性多于女性,不良反應(yīng)大多發(fā)生在用藥后1~14 d,經(jīng)過(guò)糖皮質(zhì)激素、抗過(guò)敏藥物等治療均能痊愈,沒(méi)有致死性病例報(bào)道。8例患者進(jìn)行了基因型檢測(cè),其中6例患者為HLA-B*1502陽(yáng)性,2例為HLA-B*1518/B*4001(HLA-B*1502的變異)。結(jié)論:應(yīng)當(dāng)嚴(yán)密監(jiān)測(cè)奧卡西平的不良反應(yīng),注意患者用藥教育與隨訪,必要情況下通過(guò)檢測(cè)HLA-B*1502基因可指導(dǎo)臨床合理使用奧卡西平,優(yōu)化臨床用藥方案。
[Abstract]:Objective: to investigate the clinical features and gene polymorphisms of Stevens-Johnson syndrome (SJSS) and toxic epidermal necrolysis (TEN) induced by oxcarbazepine. The case reports of severe skin adverse reactions caused by oxcarbazepine were reviewed and analyzed. Results: 12 articles were collected. A total of 13 cases of SJS/TEN caused by oxcarbazepine were reported. The severe skin adverse reactions of oxcarbazepine occurred in more men than in women, and most of the adverse reactions occurred at 1 to 14 days after treatment, and were cured by glucocorticoids and antiallergic drugs. No fatal cases were reported in which genotypes were detected in 8 patients, of whom 6 were HLA-B*1502 positive and 2 were HLA-B*1518/B*4001(HLA-B*1502 variants. Conclusion: the adverse reactions of oxcarbazepine should be closely monitored, drug education and follow-up should be paid attention to. If necessary, the detection of HLA-B*1502 gene can guide the rational use of oxcarbazepine and optimize the clinical regimen.
【作者單位】: 華中科技大學(xué)同濟(jì)醫(yī)學(xué)院附屬協(xié)和醫(yī)院藥學(xué)部;武漢市新洲區(qū)人民醫(yī)院藥學(xué)部;
【基金】:國(guó)家科技支撐計(jì)劃子課題(No.2013BAI06B04)
【分類號(hào)】:R758.59
【參考文獻(xiàn)】
相關(guān)期刊論文 前9條
1 梁艷龍;郝小生;王江濤;梁東;;兒童奧卡西平致Stevens-Johnson綜合征1例報(bào)告[J];中風(fēng)與神經(jīng)疾病雜志;2014年04期
2 孫丹;余春華;劉智勝;何雪蓮;胡家勝;吳革菲;毛冰;吳舒華;項(xiàng)慧慧;;Association of HLA-B*1502 and*1511 Allele with Antiepileptic Drug-induced Stevens-Johnson Syndrome in Central China[J];Journal of Huazhong University of Science and Technology(Medical Sciences);2014年01期
3 王菊莉;陶英賢;曹洪濤;張虎;朱金玲;;奧卡西平誘發(fā)Stevens-Johnson綜合征1例報(bào)道[J];山西醫(yī)科大學(xué)學(xué)報(bào);2013年06期
4 吝戰(zhàn)權(quán);關(guān)欣;沈司京;李曉京;韓淑玲;王寬婷;;臨床藥師參與卡馬西平致重癥型多形紅斑1例的臨床實(shí)踐[J];中國(guó)藥房;2011年38期
5 何學(xué)蓮;王芳琳;吳革菲;孫丹;康世秀;胡家勝;毛冰;何彩英;劉智勝;;奧卡西平誘發(fā)的Stevens-Johnson綜合征的臨床特點(diǎn)及基因表達(dá)[J];實(shí)用兒科臨床雜志;2011年05期
6 劉寧;齊曉漣;;奧卡西平致皮疹7例分析[J];醫(yī)藥導(dǎo)報(bào);2010年07期
7 張麗;周權(quán);;奧卡西平致嚴(yán)重藥疹反應(yīng)1例[J];天津藥學(xué);2007年05期
8 李里;袁淑華;朱雨嵐;王維治;;新型抗癲癇藥之間及其與傳統(tǒng)抗癲癇藥的相互作用和機(jī)制[J];中國(guó)新藥雜志;2007年02期
9 陳子怡;周列民;周玨倩;李偉峰;程芙蓉;潘軍利;;抗癲癇藥物所致重型藥疹及危險(xiǎn)因素分析[J];醫(yī)學(xué)信息;2006年11期
【共引文獻(xiàn)】
相關(guān)期刊論文 前10條
1 簡(jiǎn)冬群;舒健;張峰;劉麗英;陳春蓮;;卡馬西平聯(lián)合左乙拉西坦或托吡酯治療兒童難治性部分性發(fā)作癲癇的療效比較[J];臨床醫(yī)藥實(shí)踐;2017年08期
2 袁磊;劉丹琦;李逃明;王萍;尹桃;周伯庭;;丙戊酸鈉與卡馬西平血藥濃度監(jiān)測(cè)2608例次結(jié)果分析[J];中國(guó)藥師;2017年06期
3 劉穎;姚蓉;孫聞續(xù);徐s,
本文編號(hào):1639942
本文鏈接:http://sikaile.net/kejilunwen/jiyingongcheng/1639942.html